Shuttle News: November 2009 Archives

Keith's 25 Nov note: This video was compiled by the SE&I folks using all the ground, air, SRB and ET video from the STS-129 launch.

Keith's 26 Nov update: NASA SE&I had this video taken offline at YouTube. It has been reposted at Exposure Room.

STS-129 Launch Video

The first few secs of video are jumbled - just wait it is perfect after that.

STS-129 Launched

NASA: "Space shuttle Atlantis and its crew of six astronauts are headed for space, ready to begin their 11-day mission to the International Space Station. The climb to orbit takes about 8 1/2 minutes. Following a smooth countdown, with no technical issues and weather that steadily improved throughout the afternoon, the shuttle lifted off from Launch Pad 39A on-time from Launch Pad 39A at NASA's Kennedy Space Center in Florida at 2:28 p.m. EST."

@JMorrison2103: "They should have sent a poet...." #nasatweetup

@davecgibson: #nasatweetup It would be impossible to witness that and not walk away feeling optimistic about the future. just...wow.

@cabridges: Saw more than a few teary eyes after the launch before it got too blurry to see. #nasatweetup

- Follow all the Twittering at #nasatweetup
- NASA Launch Blog
- Watch live NASA TV here.

Keith's note: I just got a media advisory from Griffin Marketing (the folks behind the Coalition for Space Exploration) offering an interview opportunity with "Thomas Pickens, III, Chairman of the Board, and John Porter, CEO, Astrogenetix, regarding payload on board STS-129". The advisory states: "Astrogenetix is the first commercial space company to use microgravity to develop new medicines and vaccines."

I had to read the advisory several times to make certain that I had read it properly. I guess those involved in the generation of this advisory are unaware of McDonnell Douglas and Johnson & Johnson work on space biotech with an eye toward therapeutics back in the 1980's (Charlie Walker flew on 3 shuttle missions - see image), work that Genetech did on shuttle missions, and work that Larry DeLucas and his commerical partners did with regard to protein crystallography, on-orbit research that Amgen and Bioserve did - all with a clear, firm interest in developing therapeutics. And this is just a partial listing. I'd add links, but anyone can find them if they spend a few minutes on Google.

NASA shuttle contractor cancels merit raises for all employees, Orlando Sentinel

"United Space Alliance, NASA's main shuttle contractor, told employees today that it will be cancelingmerit payraisesacross the company next year in order to keep costs down as it tries to win new businessaftertheagencymothballs the orbiter fleet in 2011. "The annual merit pay increases for 2010 for performance and things like that, we made the decision not to do that," said company spokesman Jeff Carr. "This really about protecting our rates to be competitive for future follow on work."

KSC Job Loss Update

NASA KSC Center Director Robert Cabana Internal Memo: Seas of Change

"The Shuttle program is going to come to an end in the not too distant future. We are already transitioning to a new architecture that will enable us to once again leave our home planet. When the program does end, a significant portion of our team is going to be out of work. The International Space Station will most likely have a life beyond 2016 to probably 2020. NASA is going to support the development of commercial options to service the International Space Station; we have already been doing this through the Commercial Orbital Transportation Services program. We are going to build a spacecraft to take humans beyond low Earth orbit; its name is Orion, and it is going to be built here at KSC."


Loading

 



Monthly Archives

About this Archive

This page is an archive of entries in the Shuttle News category from November 2009.

Shuttle News: September 2009 is the previous archive.

Shuttle News: December 2009 is the next archive.

Find recent content on the main index or look in the archives to find all content.